Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
$4.55−0.17 (-3.60%)
Close on Nov 17, 2026Market cap $2.26BP/E –Yield –
Regencell Bioscience ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Regencell Bioscience
Regencell Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?